Memorial Hospital Research Laboratories

The Lee Jones Lab

Research

Lee Jones, PhD

Exercise Oncology Service

Our research group studies the utility of different methods to characterize the chronic and long-term adverse cardiovascular side effects of conventional and novel cancer therapies. By investigating the use of these tools, we can better understand how cancer therapeutics damage organs such as the heart and skeletal muscles, as well as identify those individuals at high risk of cardiovascular side effects. In doing so, we can design therapeutic interventions to prevent and/or mitigate these devastating side effects.

View Lab Overview

Research Projects

Featured News

Roundup

Highlights from ASCO 2018: Immunotherapy for Endometrial Cancer, Benefits of Exercise, and Promising New Targeted Drugs

Monday, June 4, 2018

Q&A

A Field in Motion: Fighting Cancer with Exercise

Tuesday, July 21, 2015

How Exercise May Aid Cancer Treatment

Wednesday, March 25, 2015

View All Featured News

Publications

Jones LW, Habel LA, Weltzien E, Castillo A, Gupta D, Kroenke CH, Kwan ML, Queensberry CP, Scott J, Sternfeld B, Yu, A, Kushi LH, Caan BJ. Exercise and prognosis on the basis of clinicopathologic and molecular features in early stage breast cancer: The LACE and Pathways studies. Cancer Res. 2016 Aug 3.

Scott JM, Nan L, Qi L, et al. Association of Exercise With Mortality in Adult Survivors of Childhood Cancer. JAMA Oncol. June 2018.

Jones LW, Habel LA, Weltzien E, Castillo A, Gupta D, Kroenke CH, Kwan ML, Queensberry CP, Scott J, Sternfeld B, Yu, A, Kushi LH, Caan BJ. Exercise and risk of cardiovascular events in women with non-metastatic breast cancer. J Clin Oncol. 2016 May.

Jones LW, Liu Q, Armstrong GT, Ness KK, Yasui Y, Devine K, Tonorezos E, Soares-Miranda L, Sklar CA, Douglas PS, Robison LL, Oeffinger KC. Exercise and risk of major cardiovascular events in adult survivors of childhood Hodgkin lymphoma: a report from the childhood cancer survivor study. Journal of Clinical Oncology. 2014, 32:3643-50.

Betof AS, Lascola CD, Fowler E, Scarbrough PM, Jones LW*, Dewhirst MW*. Exercise inhibits tumor progression and sensitizes tumors to chemotherapy in orthotoptic models of breast cancer. Journal of the National Cancer Institute. In Press *co-senior authorship.

View All Publications

People

Lee Jones, PhD

Exercise scientist Lee Jones focuses on the efficacy and mechanisms of exercise training on cardiovascular toxicities and tumor initiation and progression.

jonesl3@mskcc.org: Email Address

Members

Anastasia Bohajian
Clinical Research Coordinator

Diane Catalina
Clinical Research Manager

Gina Fickera
Clinical Research Coordinator

Katie Foug
Clinical Research Coordinator

Jenna Harrison
Clinical Research Specialist

Kereshmeh (Keri) Khoramabadi
Exercise Physiologist

Catherine Lee
Clinical Research Supervisor

Meghan Michalski
Exercise Physiologist Supervisor

Andrew Nixon
Exercise Physiologist Telemedicine Specialist

Kelly O'Brien
Research Regulatory Associate

Lab Alumni

Brittany Arnold
Research Study Assistant

Kristen Aufiero
Clinical Research Manager

Margaret (Meg) Bradley
Clinical Research Supervisor

Robert D’Agostino
Clinical Research Coordinator

Elizabeth Fischman
Research Study Assistant

Rebecca Hawke

Program Manager

Rebecca Hiner
Pre-Clinical Research Project Coordinator

Klaudia Koziol
Clinical Research Coordinator

Thomas Montopoli

Echocardiographer

Bharvi (Marsha) Patel
Research Study Assistant

Alexandra (Bili) Yin
Research Study Assistant

Lab Affiliations

Open Positions

Job Opportunities

Apply now

Get in Touch

jonesl3@mskcc.org

Lab Head Email

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Lee Jones discloses the following relationships and financial interests:

Pacylex
Ownership / Equity Interests

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.

View all disclosures